Health Programme DataBase - European Commission

Amr / Projects

3rd Health Programme (2014-2020)

EPHA Operating Grant Proposal 2016 SGA [EPHA SGA 2016]

The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four objectives of the Third Health Programme. EPHA has formally reviewed our Strategic Plan 2011-2015. We undertook a thorough consultation process involving Board members, Staff and the EPHA membership, and an analysis of EPHA’s operating environment, strengths and weaknesses. The EPHA membership formally approved the new Strategic Plan 2016-2020 at the Annual General Assembly on 4th September 2015. The Work Programme for 2016 reflects the revised strategy to define a clearer selection of priorities. This approach will enable EPHA to manage activities more effectively, encourage closer cooperation between members and across themes, and better monitor and evaluate our impact.EPHA’s overarching strategic objective remains: “To promote good health and wellbeing, to reduce disease and health inequalities in European policies and programmes”. Priorities selected are as follows:Under Aims 1 and 2 of the 3rdHP and EPHA Strategic Objective “Securing a Governance for Health Approach in Key EU Policies” (HiAP):- Agriculture and Food Policy including Alcohol, Tobacco and NCDs- EU Semester for Health- Healthy Trade Policy- Public Health and Research in the EU BudgetUnder Aims 3 and 4 of the 3rdHP and EPHA Strategic Objective “Strengthen EU Policies to Reduce Health Inequalities and Ensure Universal Access to Sustainable, Inclusive Health Systems”:- Universal and Fair Access to Medicines- Action on Antimicrobial Resistance- Inclusive E- and M-Health- HSPAEach of these areas has operational objectives, milestones, deliverables and impact indicators. The Work Programme 2016 also highlights organisational development objectives, particularly on cooperation with academia, communications and financial sustainability, which are priorities for 2016.

Start date: 01/01/2016 - End date: 31/12/2016

Keywords : [ Amr ] [ Anthrax ] [ Anthrax ] [ Blood ] [ Botulism ] [ Breast ] [ Brucellosis ] [ Campylobacteriosis ] [ Cancer ] [ Cardiovascular Diseases ] [ Cervical ] [ Chlamydia ] [ Cholera ] [ Chronic Diseases ] [ Chronic Diseases ] [ Chronic kidney diseases ] [ Chronic pulmonary diseases ] [ Colorectal ] [ Communicable Diseases ] [ Communicable Diseases ] [ Cryptosporidiosis ] [ Dengue fever ] [ Diabetes ] [ Diphtheria ] [ Diseases of zoonotic and environmental origin and vector borne ] [ E ] [ E/M-Health ] [ Echinococcosis ] [ Economic Policy ] [ Emergent pathogens ] [ Epilepsy ] [ Food and waterborne diseases ] [ Giardisasis ] [ Gonorrhea ] [ HIV, STIs & Blood borne infections ] [ Health Research ] [ Healthcare-associated infections ] [ Hepatitis A ] [ Hepatitis B ] [ Hepatitis C ] [ Hiap ] [ Hiv/Aids ] [ Hpv ] [ Hspa ] [ Hspa. ] [ Influenza ] [ Invasive Haemophilus influenzae disease ] [ Invasive pneumococcal disease ] [ Ischaemic heart disease ] [ Legionnaire's diseaese ] [ Leptospirosis ] [ Leptospirosis ] [ Listeriosis ] [ Lung ] [ M-Health ] [ Malaria ] [ Measles ] [ Menongoccal disease ] [ Multiple sclerosis ] [ Mumps ] [ Musculo skeletal conditions ] [ Ncds ] [ Neurological diseases and disorders ] [ Other specific diseases ] [ Parkinson's disease ] [ Participation ] [ Plague ] [ Polio ] [ Prevention ] [ Prevention ] [ Promotion ] [ Protection ] [ Public Health ] [ Qfever ] [ Rabies ] [ Respiratory tract infections ] [ Rubella ] [ SARS ] [ Salmonellosis ] [ Shigellosis ] [ Shigellosis ] [ Smallpox ] [ Stomach ] [ Stroke ] [ Syphilis ] [ Tetanus ] [ Toxoplasmosis ] [ Trade ] [ Trichinellosis ] [ Tuberculosis ] [ Tularaemia ] [ Tularemia ] [ Type I ] [ Typhoid fever ] [ Universal Access ] [ VTEC ] [ Vaccine-preventable diseases ] [ Variant Creutzfeld-Jakob disease ] [ Viral Haemorrhagic fevers ] [ West Nile fever ] [ Yellow fever ] [ Yersiniosis ] [ campylobacteriosis ] [ pertussis ] [ prostate ] [ salmonellosis ] [ skin ] [ type II ]

Call: Health Programme Adhoc Call for invited (named) beneficiaries

Topic: Amr

3rd Health Programme (2014-2020)

Proposal for a Specific Grant Agreement 2019 [EPHA 2019 SGA]

EPHA’s proposal for a Specific Grant Agreement (SGA) 2019 has been designed to be as coherent as possible with EPHA’s 2018-2021 Framework Partnership Agreement (FPA). It provides a problem analysis for the activities proposed, taking into account current developments and evidence that are influencing public health.

The proposal defines the 2019 operational SMART objectives in each priority area and how they relate to the multiannual objectives outlined in the FPA. Each 2019 objective is broken down into concrete activities, milestones and deliverables.

In line with the FPA, EPHA is seeking funding to continue working in eight thematic priority areas: prevention of chronic NCDs, access to affordable medicines, antimicrobial resistance, digital health, healthy trade policy, improving access to healthcare for disadvantaged groups, financing for public health, and capacity building. One of the main differences between the 2019 SGA proposal and previous years is that more emphasis will be placed on establishing synergies between these areas. This will enable EPHA to be more results-oriented by fostering cross-fertilisation of ideas and action, strengthening the evidence base and working effectively as a network through our diverse membership. A strong focus is placed on ensuring transfer of knowledge between the EU and national level to support the priorities of the 3rd Health Programme and the European Commission, and to emphasise the added value of EU health policymaking.

Moreover, the proposal describes the planning and implementation of EPHA’s Work Programme, including the resources required to accomplish it (staff and budget), the target audience(s) for each activity and how deliverables will be disseminated. It also shows how the work will be evaluated, with indicators provided for each objective. The final part explains how EPHA’s operational and financial management structure supports the successful delivery, with a detailed budget accompanying the proposal.

Start date: 01/01/2019 - End date: 31/12/2019

Keywords : [ Access To Medicines And Healthcare ] [ Amr ] [ Chronic Diseases ] [ Civil Society ] [ Communicable Diseases ] [ Disadvantaged Groups ] [ Disadvantaged Groups ] [ Health Professionals ] [ Health Promotion ] [ Patients ] [ Prevention ] [ Public Health ]

Call: Financial contribution to the functioning of non-governmental bodies (Operating grants)

Topic: Amr

3rd Health Programme (2014-2020)

Proposal for a Specific Grant Agreement 2020 [EPHA 2020 SGA]

EPHA's 2020 SGA work programme will build on the activities implemented in 2018 - 2019 with a view to attaining the objectives outlined in the 2018-2021 FPA in eight thematic priority areas: NCD prevention, access to medicines, antimicrobial resistance, digital health, healthy trade, access to health and care for disadvantaged groups, financing for public health and capacity building / organisational development. Each thematic priority includes its own operational objective for 2020 and is broken down into activities including milestones and 20 deliverables. Process, output and outcome indicators are provided for the corresponding specific objectives.
EPHA and its members will continue creating synergies between these areas to strengthen the evidence base, identify best practices and enable policy dialogue between the EU and national level. The beneficiaries are numerous: policymakers, civil society and the public. EPHA will support EU policymakers to better respond to the real health needs of ordinary people, while national stakeholders will be able to make better use of EU policies to play a more active role in EU policy-making.
The implementation of the Sustainable Development Goals will be a thread running through all areas given that the issues EPHA is working on are multisectoral, involving both health and non-health stakeholders. We will work to ensure that reducing health inequalities will remain a priority in the context of the European Pillar of Social Rights and European Semester implementation.
A special focus will be placed on advocating public health friendly policies among new EU officials following the institutional renewal process, as well as newly elected MEPs who joined the European Parliament in 2019. This will be important for shaping the post-2020 policy and funding frameworks that will determine the level of attention paid to public health in general and to the inclusion of disadvantaged groups, including in the digital realm.

Start date: 01/01/2020 - End date: 31/12/2020

Keywords : [ Access To Medicines ] [ Amr ] [ Capacity Building ] [ Chronic Ncds ] [ Digitalisation ] [ Financing For Public Health ] [ Health Inequalities ] [ Health Professionals ] [ Patients ] [ Sdgs ] [ Trade ] [ Universal Health Coverage ]

Call: Financial Contribution to the Functioning of Non-Governmental Bodies - Invitation to submit proposals for Specific Operating Grant Agreements (SGA)

Topic: Amr

3rd Health Programme (2014-2020)

2021 Specific Grant Agreement - European Public Health Alliance (EPHA) [2021-SGA-EPHA]

EPHA's 2021 SGA proposal includes the continuation of activities in eight thematic priorities, designed to conclude the multiannual 2018-2021 FPA and reach its objectives. This will provide ongoing support to all areas of the Third Health Programme despite its formal expiry at the end of 2020.

Crucially, EPHA proposes to broaden its activities in light of the new European Commission priorities announced in 2019, and the significant socio-economic challenges, policy and funding opportunities for public health resulting from the 2020 COVID-19 outbreak. Moreover, 2021 will be a year of transition for EPHA as a new Strategic Plan will be implemented that will contain flexible policy clusters. Therefore, the 2021 SGA proposal incorporates activities in relation to the pandemic recovery process, the EU Green Deal, increased digitalisation and other pressing issues.

A big focus will be placed on developing EPHA's "financing for health" thematic priority, which suffered from lower resources in previous years. Given the the unprecedented EU funding available to tackle health threats and ensure health systems strengthening, EPHA aims to play a key role in ensuring that available funding streams will be spent wisely, inter alia to boost prevention, avoid new health/social inequalities and avoid austerity policies in health.

EPHA’s annual work programme will provide added EU value by supporting policymakers and civil society through the development of policy recommendations, best practice exchanges and peer learning, linking up EU and national public health stakeholders and building capacity.

The work will be undertaken by EPHA’s Secretariat team, supported by interns, trainees and external consultants contributing to specific deliverables and milestones.

Start date: 01/01/2021 - End date: 31/12/2021

Keywords : [ Access To Medicines ] [ Amr ] [ Capacity Building ] [ Communicable Diseases ] [ Digital Healthcare ] [ Health Financing ] [ Health Inequalities ] [ Health Promotion ] [ Ncd Prevention ] [ Pandemic Recovery ] [ Public Health ]

Call: Invitation to submit proposals for Specific Operating Grants (SGA) for the year 2021 under the Annual Work Programme 2020 of 3HP

Topic: Amr

3rd Health Programme (2014-2020)

Dutch EU Presidency Conference on Antimicrobial Resistance [EU.NL-AMR]

During their EU Presidency, the Netherlands will organize a Ministerial Conference on Antibiotic Resistance on the 9th (evening only) and 10th of February 2016 in Amsterdam. All EU/EEA Ministers for Health and Agriculture will be invited. Aims is to discuss progress to combate AMR in the EU so far and the need for (measurable) action in the near future, with a focus on a One Health approach.
The conference should lead to an outcome document, and be adopted in both Health and Agriculture Council.

Start date: 01/11/2015 - End date: 31/07/2016

Keywords : [ Amr ] [ Precidency ]

Call: Health Programme Adhoc Call for invited (named) beneficiaries

Topic: Amr